Naratriptan

CAS 121679-13-8 0 current recordsSmall Molecule

Who holds supplier records for Naratriptan? No organisation holds a current US Type II DMF or EU CEP for Naratriptan in the registers PharmaTek covers.

Most records are filed under another form of this substance: Naratriptan Hydrochloride (4 current sources). A DMF or CEP is listed under the form it names.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Naratriptan: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/naratriptan

Reading the evidence

  • No current DMF or CEP on record

    The covered registers hold no supplier record for this substance. This is not evidence that no one makes it: suppliers may file under another name, sell outside the US and EU, or use an ASMF.

Current records (0)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Naratriptan. Country is the organisation's recorded country, not necessarily the manufacturing site.

Not found in the covered registers (FDA DMF list, EDQM). This is not evidence that no supplier exists.

Need Naratriptan sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Naratriptan is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1278).

Chemical identity

IUPAC name
N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide
Canonical SMILES
CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
InChIKey
AMKVXSZCKVJAGH-UHFFFAOYSA-N
Synonyms
Naratriptan, Naramig, naratriptanum, CHEBI:7478, RefChem:57988, N02CC02, Naratriptan (INN), Colatan, NARATRIPTAN [INN], Naramig (TN), Naratriptan [INN:BAN], NARATRIPTAN [MI]

Record history

No change to the current records between 11 Nov 2026 and 12 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.
For suppliers

Do you supply Naratriptan?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.